Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus

Established organ damage reduces belimumab efficacy in systemic lupus erythematosus

(2019) Ioannis Parodis et al.   ANNALS OF THE RHEUMATIC DISEASES

Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

(2019) Shereen Oon et al.   ANNALS OF THE RHEUMATIC DISEASES

Smoking reduces the efficacy of belimumab in mucocutaneous lupus

(2018) Ioannis Parodis et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

(2018) Antonis Fanouriakis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

(2015) Kate Franklyn et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologics in SLE: Towards new approaches

(2013) Ronald F. van Vollenhoven et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Glucocorticoid use and abuse in SLE

(2012) G. Ruiz-Irastorza et al.   RHEUMATOLOGY

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

(2009) Daniel J. Wallace et al.   ARTHRITIS AND RHEUMATISM

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM